Search research articles
Contact Us
Filters
Showing results (261-270 of 298) with videos related to
Page
of 30
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
February 12, 2026
Viral shedding and symptom severity across populations during acute COVID in the ACTIV-2 study
Evelyn Kung, Rinki Deo, Manish C Choudhary, et al.
The Lancet. HIV
|
April 5, 2026
Pitavastatin effects on lipids in relation to major adverse cardiovascular events: a REPRIEVE secondary analysis
Triin Umbleja, Mohammad U Zafar, Sara McCallum, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 12, 2022
Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infection
Julie Boucau, Kara W Chew, Manish Choudhary, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 5, 2024
Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate-Containing Antiretroviral Treatment Regimens During Pregnancy and Postpartum
Risa M Hoffman, Sean Brummel, Lauren Ziemba, et al.
The New England Journal of Medicine
|
February 25, 2026
Tecovirimat for the Treatment of Mpox
Jason Zucker, William A Fischer, Lu Zheng, et al.
Cell Reports. Medicine
|
July 6, 2022
Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infection
Julie Boucau, Kara W Chew, Manish C Choudhary, et al.
The New England Journal of Medicine
|
October 15, 2010
Antiretroviral therapies in women after single-dose nevirapine exposure
Shahin Lockman, Michael D Hughes, James McIntyre, et al.
Annals of Internal Medicine
|
October 7, 2014
Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial
Jeffrey L Lennox, Raphael J Landovitz, Heather J Ribaudo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 14, 2022
Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United States
Markella V Zanni, Borek Foldyna, Sara McCallum, et al.
JAMA Network Open
|
April 26, 2023
Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19: 2 Randomized Clinical Trials
Rachel A Bender Ignacio, Kara W Chew, Carlee Moser, et al.
Page
of 30
Search research articles
Search
Showing results (261-270 of 298) with videos related to
Sort By:
Page
of 30
Medrxiv : the Preprint Server for Health Sciences
|
February 12, 2026
Viral shedding and symptom severity across populations during acute COVID in the ACTIV-2 study
Evelyn Kung, Rinki Deo, Manish C Choudhary, et al.
The Lancet. HIV
|
April 5, 2026
Pitavastatin effects on lipids in relation to major adverse cardiovascular events: a REPRIEVE secondary analysis
Triin Umbleja, Mohammad U Zafar, Sara McCallum, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 12, 2022
Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infection
Julie Boucau, Kara W Chew, Manish Choudhary, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 5, 2024
Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate-Containing Antiretroviral Treatment Regimens During Pregnancy and Postpartum
Risa M Hoffman, Sean Brummel, Lauren Ziemba, et al.
The New England Journal of Medicine
|
February 25, 2026
Tecovirimat for the Treatment of Mpox
Jason Zucker, William A Fischer, Lu Zheng, et al.
Cell Reports. Medicine
|
July 6, 2022
Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infection
Julie Boucau, Kara W Chew, Manish C Choudhary, et al.
The New England Journal of Medicine
|
October 15, 2010
Antiretroviral therapies in women after single-dose nevirapine exposure
Shahin Lockman, Michael D Hughes, James McIntyre, et al.
Annals of Internal Medicine
|
October 7, 2014
Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial
Jeffrey L Lennox, Raphael J Landovitz, Heather J Ribaudo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 14, 2022
Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United States
Markella V Zanni, Borek Foldyna, Sara McCallum, et al.
JAMA Network Open
|
April 26, 2023
Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19: 2 Randomized Clinical Trials
Rachel A Bender Ignacio, Kara W Chew, Carlee Moser, et al.
Page
of 30